| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VACCINEX, INC. | SVP, Development | Stock Option (Right to Buy) | 20,000 | $15,400 | $0.7700 | 31 Mar 2023 | Direct |
| VACCINEX, INC. | SVP, Development | Common Stock | 2,258 | $1,626 | $0.7200 | 31 Mar 2023 | Direct |
| VACCINEX, INC. | SVP, Development | Common Stock | 1,014 | $730 | $0.7200 | 31 Mar 2023 | By John Leonard Consulting, LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VCNX | VACCINEX, INC. | 31 Mar 2023 | 1 | $0 | 4 | SVP, Development | 03 Apr 2023, 16:35 |
| VCNX | VACCINEX, INC. | 01 Apr 2022 | 1 | $0 | 4 | SVP, Development | 04 Apr 2022, 16:36 |